OpenAlex
PricingAboutJobs
Log inGet started
Work

Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine.

PubMed

Year: 2001
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: J C Bystryn, A Zeleniuch-Jacquotte, R Oratz, R L Shapiro, M N Harris, D F Roses
Institutions: NYU Langone Health, New York University
Language: English

Topic: Cutaneous Melanoma Detection and Management
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: melanoma vaccine, multivalent vaccine, resected melanoma, regional lymph node metastasis, stage III melanoma, disease progression, overall survival, alum adjuvant, immunotherapy, humoral and cellular immune response
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Awards: POTENTIATION OF CD8+ T CELL RESPONSE TO MELANOMA VACCINE, PEPTIDE SPECIFIC CD8 T CELLS AS MARKER OF VACCINE ACTION
OpenAlex ID: W2162570492
FWCI: 5.761
Cites: 22
Cited by: 110
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security